Diagnostic value of troponin T for alterations in left ventricular mass and function in dialysis patients

Francesca Mallamaci, Carmine Zoccali, Saverio Parlongo, Giovanni Tripepi, Francesco A. Benedetto, Sebastiano Cutrupi, Grazia Bonanno, Pasquale Fatuzzo, Francesco Rapisarda, Giuseppe Seminara, Benedetta Stancanelli, Ignazio Bellanuova, Alessando Cataliotti, Lorenzo S. Malatino

Research output: Contribution to journalArticle

61 Citations (Scopus)

Abstract

Background. Cardiac troponin T (cTnT) is related to left ventricular (LV) mass in patients with end-stage renal disease (ESRD). Furthermore, cTnT reflects the severity of systolic dysfunction in patients with heart diseases. We tested the diagnostic value of cTnT for left ventricular hypertrophy (LVH) and LV systolic dysfunction in a large group of clinically stable hemodialysis patients without heart failure. Results. CTnT was significantly (P < 0.001) higher in patients with LVH than in those with normal LV mass. In a multiple logistic regression model, adjusting for potential confounders (including cardiac ischemia), systolic pressure and cTnT (both P = 0.003) were the strongest correlates of LVH. Similarly, cTnT was significantly higher (P = 0.005) in patients with systolic dysfunction than in those with normal LV function and in a multiple logistic regression model cTnT ranked as the second independent correlate of this alteration after male sex. Serum cTnT had a high positive prediction value for the diagnosis of LVH (87%) but its negative prediction value was relatively low (44%). The positive predictive value of cTnT for LV dysfunction was low (25%) while its negative predictive value was high (93%). A combined analysis including systolic pressure (for the diagnosis of LVH) and sex (for the diagnosis of LV systolic dysfunction) augmented the diagnostic estimates to an important extent (95% positive prediction value for LVH and 98% negative prediction value for LV systolic dysfunction). Conclusions. CTnT has a fairly good diagnostic potential for the identification of LVH and for the exclusion of LV systolic dysfunction in patients with ESRD without heart failure. This marker may be useful for the screening of alterations in LV mass and function in clinically stable hemodialysis patients.

Original languageEnglish (US)
Pages (from-to)1884-1890
Number of pages7
JournalKidney International
Volume62
Issue number5
DOIs
StatePublished - 2002
Externally publishedYes

Fingerprint

Troponin T
Left Ventricular Function
Left Ventricular Hypertrophy
Dialysis
Left Ventricular Dysfunction
Logistic Models
Chronic Kidney Failure
Renal Dialysis
Heart Failure
Blood Pressure
Heart Diseases
Ischemia
Serum

Keywords

  • Cardiovascular risk
  • Diagnosis
  • End-stage renal disease
  • Hemodialysis
  • Hypertension
  • Left ventricular hypertrophy
  • Uremia

ASJC Scopus subject areas

  • Nephrology

Cite this

Mallamaci, F., Zoccali, C., Parlongo, S., Tripepi, G., Benedetto, F. A., Cutrupi, S., ... Malatino, L. S. (2002). Diagnostic value of troponin T for alterations in left ventricular mass and function in dialysis patients. Kidney International, 62(5), 1884-1890. https://doi.org/10.1046/j.1523-1755.2002.00641.x

Diagnostic value of troponin T for alterations in left ventricular mass and function in dialysis patients. / Mallamaci, Francesca; Zoccali, Carmine; Parlongo, Saverio; Tripepi, Giovanni; Benedetto, Francesco A.; Cutrupi, Sebastiano; Bonanno, Grazia; Fatuzzo, Pasquale; Rapisarda, Francesco; Seminara, Giuseppe; Stancanelli, Benedetta; Bellanuova, Ignazio; Cataliotti, Alessando; Malatino, Lorenzo S.

In: Kidney International, Vol. 62, No. 5, 2002, p. 1884-1890.

Research output: Contribution to journalArticle

Mallamaci, F, Zoccali, C, Parlongo, S, Tripepi, G, Benedetto, FA, Cutrupi, S, Bonanno, G, Fatuzzo, P, Rapisarda, F, Seminara, G, Stancanelli, B, Bellanuova, I, Cataliotti, A & Malatino, LS 2002, 'Diagnostic value of troponin T for alterations in left ventricular mass and function in dialysis patients', Kidney International, vol. 62, no. 5, pp. 1884-1890. https://doi.org/10.1046/j.1523-1755.2002.00641.x
Mallamaci, Francesca ; Zoccali, Carmine ; Parlongo, Saverio ; Tripepi, Giovanni ; Benedetto, Francesco A. ; Cutrupi, Sebastiano ; Bonanno, Grazia ; Fatuzzo, Pasquale ; Rapisarda, Francesco ; Seminara, Giuseppe ; Stancanelli, Benedetta ; Bellanuova, Ignazio ; Cataliotti, Alessando ; Malatino, Lorenzo S. / Diagnostic value of troponin T for alterations in left ventricular mass and function in dialysis patients. In: Kidney International. 2002 ; Vol. 62, No. 5. pp. 1884-1890.
@article{59a32f1923e84aeaa1d10373e0d6c8cb,
title = "Diagnostic value of troponin T for alterations in left ventricular mass and function in dialysis patients",
abstract = "Background. Cardiac troponin T (cTnT) is related to left ventricular (LV) mass in patients with end-stage renal disease (ESRD). Furthermore, cTnT reflects the severity of systolic dysfunction in patients with heart diseases. We tested the diagnostic value of cTnT for left ventricular hypertrophy (LVH) and LV systolic dysfunction in a large group of clinically stable hemodialysis patients without heart failure. Results. CTnT was significantly (P < 0.001) higher in patients with LVH than in those with normal LV mass. In a multiple logistic regression model, adjusting for potential confounders (including cardiac ischemia), systolic pressure and cTnT (both P = 0.003) were the strongest correlates of LVH. Similarly, cTnT was significantly higher (P = 0.005) in patients with systolic dysfunction than in those with normal LV function and in a multiple logistic regression model cTnT ranked as the second independent correlate of this alteration after male sex. Serum cTnT had a high positive prediction value for the diagnosis of LVH (87{\%}) but its negative prediction value was relatively low (44{\%}). The positive predictive value of cTnT for LV dysfunction was low (25{\%}) while its negative predictive value was high (93{\%}). A combined analysis including systolic pressure (for the diagnosis of LVH) and sex (for the diagnosis of LV systolic dysfunction) augmented the diagnostic estimates to an important extent (95{\%} positive prediction value for LVH and 98{\%} negative prediction value for LV systolic dysfunction). Conclusions. CTnT has a fairly good diagnostic potential for the identification of LVH and for the exclusion of LV systolic dysfunction in patients with ESRD without heart failure. This marker may be useful for the screening of alterations in LV mass and function in clinically stable hemodialysis patients.",
keywords = "Cardiovascular risk, Diagnosis, End-stage renal disease, Hemodialysis, Hypertension, Left ventricular hypertrophy, Uremia",
author = "Francesca Mallamaci and Carmine Zoccali and Saverio Parlongo and Giovanni Tripepi and Benedetto, {Francesco A.} and Sebastiano Cutrupi and Grazia Bonanno and Pasquale Fatuzzo and Francesco Rapisarda and Giuseppe Seminara and Benedetta Stancanelli and Ignazio Bellanuova and Alessando Cataliotti and Malatino, {Lorenzo S.}",
year = "2002",
doi = "10.1046/j.1523-1755.2002.00641.x",
language = "English (US)",
volume = "62",
pages = "1884--1890",
journal = "Kidney International",
issn = "0085-2538",
publisher = "Nature Publishing Group",
number = "5",

}

TY - JOUR

T1 - Diagnostic value of troponin T for alterations in left ventricular mass and function in dialysis patients

AU - Mallamaci, Francesca

AU - Zoccali, Carmine

AU - Parlongo, Saverio

AU - Tripepi, Giovanni

AU - Benedetto, Francesco A.

AU - Cutrupi, Sebastiano

AU - Bonanno, Grazia

AU - Fatuzzo, Pasquale

AU - Rapisarda, Francesco

AU - Seminara, Giuseppe

AU - Stancanelli, Benedetta

AU - Bellanuova, Ignazio

AU - Cataliotti, Alessando

AU - Malatino, Lorenzo S.

PY - 2002

Y1 - 2002

N2 - Background. Cardiac troponin T (cTnT) is related to left ventricular (LV) mass in patients with end-stage renal disease (ESRD). Furthermore, cTnT reflects the severity of systolic dysfunction in patients with heart diseases. We tested the diagnostic value of cTnT for left ventricular hypertrophy (LVH) and LV systolic dysfunction in a large group of clinically stable hemodialysis patients without heart failure. Results. CTnT was significantly (P < 0.001) higher in patients with LVH than in those with normal LV mass. In a multiple logistic regression model, adjusting for potential confounders (including cardiac ischemia), systolic pressure and cTnT (both P = 0.003) were the strongest correlates of LVH. Similarly, cTnT was significantly higher (P = 0.005) in patients with systolic dysfunction than in those with normal LV function and in a multiple logistic regression model cTnT ranked as the second independent correlate of this alteration after male sex. Serum cTnT had a high positive prediction value for the diagnosis of LVH (87%) but its negative prediction value was relatively low (44%). The positive predictive value of cTnT for LV dysfunction was low (25%) while its negative predictive value was high (93%). A combined analysis including systolic pressure (for the diagnosis of LVH) and sex (for the diagnosis of LV systolic dysfunction) augmented the diagnostic estimates to an important extent (95% positive prediction value for LVH and 98% negative prediction value for LV systolic dysfunction). Conclusions. CTnT has a fairly good diagnostic potential for the identification of LVH and for the exclusion of LV systolic dysfunction in patients with ESRD without heart failure. This marker may be useful for the screening of alterations in LV mass and function in clinically stable hemodialysis patients.

AB - Background. Cardiac troponin T (cTnT) is related to left ventricular (LV) mass in patients with end-stage renal disease (ESRD). Furthermore, cTnT reflects the severity of systolic dysfunction in patients with heart diseases. We tested the diagnostic value of cTnT for left ventricular hypertrophy (LVH) and LV systolic dysfunction in a large group of clinically stable hemodialysis patients without heart failure. Results. CTnT was significantly (P < 0.001) higher in patients with LVH than in those with normal LV mass. In a multiple logistic regression model, adjusting for potential confounders (including cardiac ischemia), systolic pressure and cTnT (both P = 0.003) were the strongest correlates of LVH. Similarly, cTnT was significantly higher (P = 0.005) in patients with systolic dysfunction than in those with normal LV function and in a multiple logistic regression model cTnT ranked as the second independent correlate of this alteration after male sex. Serum cTnT had a high positive prediction value for the diagnosis of LVH (87%) but its negative prediction value was relatively low (44%). The positive predictive value of cTnT for LV dysfunction was low (25%) while its negative predictive value was high (93%). A combined analysis including systolic pressure (for the diagnosis of LVH) and sex (for the diagnosis of LV systolic dysfunction) augmented the diagnostic estimates to an important extent (95% positive prediction value for LVH and 98% negative prediction value for LV systolic dysfunction). Conclusions. CTnT has a fairly good diagnostic potential for the identification of LVH and for the exclusion of LV systolic dysfunction in patients with ESRD without heart failure. This marker may be useful for the screening of alterations in LV mass and function in clinically stable hemodialysis patients.

KW - Cardiovascular risk

KW - Diagnosis

KW - End-stage renal disease

KW - Hemodialysis

KW - Hypertension

KW - Left ventricular hypertrophy

KW - Uremia

UR - http://www.scopus.com/inward/record.url?scp=18644362743&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=18644362743&partnerID=8YFLogxK

U2 - 10.1046/j.1523-1755.2002.00641.x

DO - 10.1046/j.1523-1755.2002.00641.x

M3 - Article

VL - 62

SP - 1884

EP - 1890

JO - Kidney International

JF - Kidney International

SN - 0085-2538

IS - 5

ER -